Anlotinib plus platinum‐etoposide as a first‐line treatment for extensive‐stage small cell lung cancer: A single‐arm trial.
Saved in:
| Title: | Anlotinib plus platinum‐etoposide as a first‐line treatment for extensive‐stage small cell lung cancer: A single‐arm trial. |
|---|---|
| Authors: | Deng, Pengbo1,2,3,4,5,6 (AUTHOR), Hu, Chengping1,2,3,4,5,6 (AUTHOR), Chen, Cen7 (AUTHOR), Cao, Liming1,2,3,4,5,6 (AUTHOR), Gu, Qihua1,2,3,4,5,6 (AUTHOR), An, Jian1,2,3,4,5,6 (AUTHOR), Qin, Ling1,2,3,4,5,6 (AUTHOR), Li, Min1,2,3,4,5,6 (AUTHOR), He, Baimei2,6,8 (AUTHOR), Jiang, Juan1,2,3,4,5,6 (AUTHOR), Yang, Huaping1,2,3,4,5,6 (AUTHOR) yhp9956@csu.edu.cn |
| Source: | Cancer Medicine. Oct2022, Vol. 11 Issue 19, p3563-3571. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.4736 |